U.S. Oil and Gas Stock News

NYSE:KMPR
NYSE:KMPRInsurance

The Bull Case For Kemper (KMPR) Could Change Following Q1 Loss, Smaller Credit Line, Steady Dividend

Kemper Corporation recently reported that it swung to a net loss of US$1.7 million for the first quarter of 2026, reduced its credit facility from US$600 million to US$350 million effective May 4, 2026, and affirmed a quarterly dividend of US$0.3200 per share payable on June 2, 2026. The combination of a move into loss-making territory, a smaller revolving credit line, and a maintained dividend raises important questions about Kemper's earnings resilience and balance-sheet flexibility. We...
NYSE:SFL
NYSE:SFLOil and Gas

Assessing SFL Corporation (SFL) Valuation After Strong Q1 2026 Results And Dividend Increase

Q1 results put SFL (NYSE:SFL) in focus SFL (NYSE:SFL) has drawn fresh attention after reporting Q1 2026 revenue of US$174.48 million and net income of US$26.08 million, along with a higher quarterly dividend and an extended share repurchase plan. See our latest analysis for SFL. The Q1 update follows a strong run in the stock, with the share price up 58.17% year to date and a 1 year total shareholder return of 56.99%. This performance has been supported by the dividend increase, the new...
NYSE:CMC
NYSE:CMCMetals and Mining

Will UBS’ Rebar Outlook, State Street Stake and New Director Change Commercial Metals’ (CMC) Narrative?

Earlier this week, UBS upgraded Commercial Metals Company’s rating, citing reduced downside risks to U.S. rebar pricing as import pressures appear to have peaked and trade duties progress. At the same time, State Street disclosed a passive 6.6% stake and Commercial Metals added industrial veteran Michael Dumais to its board, signaling institutional interest and governance depth around a changing market backdrop. Next, we’ll examine how easing U.S. rebar pricing risks could reshape Commercial...
NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics (HAE) Valuation Check As Earnings Pressure And Options Volatility Raise Questions

Options activity and recent earnings put Haemonetics in focus Haemonetics (HAE) has moved onto many investors’ watchlists after a jump in implied volatility for its near term options, coming just days after earnings that paired steady sales with weaker profitability. See our latest analysis for Haemonetics. The stock has been under pressure despite ongoing corporate activity, with the share price down 29.62% year to date and the 1 year total shareholder return declining 19.94%, pointing to...
NYSE:PHM
NYSE:PHMConsumer Durables

Is It Time To Reconsider PulteGroup (PHM) After Recent Share Price Pullback?

Wondering if PulteGroup at around US$110 per share still offers value, or if most of the upside has already played out. The stock has been choppy recently, with the share price down 6.3% over the past week and 13.0% over the past month, even though it is still up 6.3% over the last year and 107.2% over five years. These swings have arrived as housing and construction stocks continue to be closely watched and investors reassess how sensitive the sector might be to changing conditions. For...
NYSE:AMRC
NYSE:AMRCConstruction

Is It Too Late To Consider Ameresco (AMRC) After A 121% One Year Rally?

Wondering if Ameresco at around US$33.03 is still offering value after a strong run, or if you are arriving late to the story. The stock has posted returns of 10.2% over the past week, 27.7% over the past month, 7.7% year to date and 120.8% over the past year, while the 3 year and 5 year periods show declines of 23.6% and 36.7%. Recent price moves sit against a backdrop of ongoing attention on clean energy infrastructure companies and investor interest in how these businesses are positioned...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

J&J Snack Foods (JJSF) Is Down 6.3% After Softer Q2 Results And Completed Buyback Program

J&J Snack Foods Corp. recently reported second-quarter 2026 results showing sales of US$344.82 million and net income of US$1.68 million, both lower than a year earlier, alongside a completed repurchase of 259,889 shares for US$21.98 million. While earnings for both the quarter and six-month period weakened year on year, management also reduced the share count, which can modestly support per-share metrics. We’ll now examine how this softer revenue and earnings performance, paired with the...
NYSE:GEL
NYSE:GELOil and Gas

What Genesis Energy (GEL)'s Profit Rebound and Phantom Unit Awards Mean For Shareholders

Genesis Energy, L.P. recently reported first-quarter 2026 results, with sales rising to US$446.56 million from US$398.31 million a year earlier and net income improving to US$6.8 million from a very large net loss in the prior-year period. Alongside this operational rebound, the partnership awarded multi-year, cash-settled phantom units to its senior leadership team, tying their compensation more closely to long-term business performance. Against this backdrop of higher revenue and renewed...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Assessing Harmony Biosciences (HRMY) Valuation After Softer Earnings But Stronger Free Cash Flow

Harmony Biosciences Holdings (HRMY) is back in focus after its latest quarterly report showed net income of US$32.49 million for the March 2026 quarter, lower than the US$45.56 million reported a year earlier. See our latest analysis for Harmony Biosciences Holdings. Despite the softer earnings and a series of routine governance updates at the 2026 Annual Meeting, the stock has retreated, with the share price down 16.44% over 90 days and the year to date share price return down 19.50%. The 1...
NasdaqCM:INVZ
NasdaqCM:INVZElectronic

Does Innoviz’s Defense Pivot and Q1 Miss Reframe the Bull Case For Innoviz Technologies (INVZ)?

In May 2026, Innoviz Technologies reported first-quarter 2026 revenue of US$7.13 million versus US$17.39 million a year earlier, with net loss widening to US$26.2 million, while reaffirming full-year revenue guidance of US$67 million to US$73 million. A flurry of new agreements across defense and autonomous mobility, including framework deals with Kela Technologies and LOXO and an on-sensor software evaluation with an autonomous driving partner, highlights Innoviz’s push to diversify beyond...
NasdaqGS:ISSC
NasdaqGS:ISSCAerospace & Defense

Does Innovative Aerosystems' (ISSC) Acquisition Push Reveal a New Phase in Its Avionics Strategy?

In May 2026, Innovative Aerosystems, Inc. reported fiscal second-quarter results showing revenue of US$22.37 million and adjusted earnings per share of US$0.26, exceeding analyst expectations despite lower GAAP net income year-on-year. Alongside the earnings release, management highlighted an active acquisition pipeline, including interest in potential Honeywell divestitures, aiming to broaden its avionics portfolio and recurring aftermarket exposure. We’ll now examine how this earnings...
NYSE:UWMC
NYSE:UWMCDiversified Financial

Is UWM Holdings (UWMC) Now Attractive After Recent Share Price Weakness?

Wondering whether UWM Holdings at around US$3.00 is a bargain or a value trap? This article breaks down what the current price might be implying about the stock. The share price has been under pressure, with returns declining 11.2% over the past week, 23.5% over the past month, 32.0% year to date, and 24.3% over the past year. The 3 year and 5 year returns are down 25.8% and 45.8% respectively. Recent coverage around UWM Holdings has focused on the stock itself rather than any single...
NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

MBX Biosciences (MBX) Is Down 20.8% After Wider Loss, Obesity Data And New CCO - Has The Bull Case Changed?

MBX Biosciences recently reported a first-quarter 2026 net loss of US$23.52 million, released encouraging early obesity pipeline data, and named industry veteran Mark R. Soued as Chief Commercial Officer. The combination of once-monthly obesity candidates and a seasoned commercial leader with major launch experience marks an important shift toward preparing MBX’s pipeline for potential future commercialization. Next, we’ll examine how MBX’s once-monthly obesity trial results could influence...
NasdaqGM:AIAI
NasdaqGM:AIAIIT

AIAI Holdings Joins NASDAQ Composite What Listing Means For Future Dividends

AIAI Holdings (NasdaqGM:AIAI) completed a direct listing on the NASDAQ Global Market. The company has been added to the NASDAQ Composite Index following its listing. These steps expand AIAI Holdings' access to U.S. equity markets and index-linked capital. AIAI Holdings, now trading under the ticker NasdaqGM:AIAI, enters one of the most closely watched equity platforms globally at a time when index membership can influence both liquidity and investor mix. For readers tracking listed...
NYSE:BRSL
NYSE:BRSLHospitality

Brightstar Lottery (BRSL) Valuation After Strong Q1 Results Outlook Reaffirmation And New Contract Wins

Brightstar Lottery (BRSL) just posted first quarter 2026 results that showed higher earnings on essentially flat revenue, reaffirmed its full year outlook and backed this up with a dividend, ongoing buybacks and contract wins. See our latest analysis for Brightstar Lottery. Despite the stronger first quarter earnings, Brightstar Lottery's share price is down 18.4% over the past month and 29.9% year to date, while the 1 year total shareholder return is down 19.4%. This points to fading...
NYSE:VTOL
NYSE:VTOLEnergy Services

Reaffirmed Revenue Guidance and Rising Costs Could Be A Game Changer For Bristow Group (VTOL)

Bristow Group Inc. recently reported first-quarter 2026 results, posting sales of US$388.71 million and net income of US$13.11 million, while reaffirming full-year 2026 revenue guidance of US$1.58 billion to US$1.69 billion. The company also confirmed it has completed a relatively small share repurchase program and is absorbing higher repair, maintenance, and fleet-retirement costs that are weighing on profitability despite solid revenue performance. We will now examine how reaffirmed...
NYSE:IP
NYSE:IPPackaging

Assessing International Paper (IP) Shares After A Steep Pullback And Undervaluation Debate

Recent share performance and business backdrop International Paper (IP) has drawn investor attention after a period of weaker share performance, with the stock down 4% over the past day, 8% over the past week, and 18% over the past month. Over the past 3 months the share price has fallen 38%, while the 1-year total return is down 37%. In this market backdrop, investors are weighing the company’s current valuation against its reported revenue of US$24.3b and a net loss of US$2.6b. See our...
NasdaqCM:TH
NasdaqCM:THHospitality

Target Hospitality (TH) Is Up 21.7% After Landing Major AI Infrastructure Deal And Raising Guidance – Has The Bull Case Changed?

In the first quarter of 2026, Target Hospitality Corp. reported higher sales of US$16.58 million and revenue of US$72.78 million, but its net loss widened to US$12.92 million and loss per share increased to US$0.13 compared with the prior year. A new multi-year contract expected to generate more than US$750 million in revenue and tied to AI infrastructure development prompted management to raise full-year 2026 guidance, signaling that long-term contract visibility is becoming increasingly...
NasdaqGM:BZAI
NasdaqGM:BZAISemiconductor

A Look At Blaize Holdings (BZAI) Valuation After NeoTensr Fraud Allegations And Sharp Share Price Drop

Attention on Blaize Holdings (BZAI) has shifted sharply to legal and governance risk after a short seller accused the company of fraud related to a reported $50 million NeoTensr deal, prompting multiple law firm investigations. See our latest analysis for Blaize Holdings. Legal questions around the NeoTensr deal have coincided with sharp pressure on Blaize Holdings' share price, with a 1 day share price return of down 26% and a 7 day return of down 30%. This compares with a 3 year total...
NYSE:PNR
NYSE:PNRMachinery

Is It Time To Revisit Pentair (PNR) After The Recent Share Price Slump?

Investors may be wondering whether Pentair at around US$72.68 is starting to look like value, or if the recent weakness is a warning sign. The stock is down 5.4% over the past week, 20.2% over the past month and 31.1% year to date, with a 27.4% decline over the last year, even though the 3 year and 5 year returns sit at 27.1% and 14.0% respectively. Recent market attention has centered on Pentair as investors reassess capital goods stocks. Sector sentiment and macro headlines are both...
NasdaqGS:TBBK
NasdaqGS:TBBKBanks

Is Sticky Inflation And Higher-For-Longer Rates Altering The Investment Case For Bancorp (TBBK)?

Earlier this past week, The Bancorp’s outlook was reassessed as higher-than-expected April CPI data reinforced expectations that US interest rates may remain elevated for longer, reshaping how investors view banks’ earning power in a persistent inflation setting. Amid this macro shift, Bancorp has been framed as more sensitive to economy-wide rate and deposit trends than to immediate changes in its own fundamentals, highlighting how broader monetary policy signals can influence perceived...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Why Liquidia (LQDA) Is Up 34.6% After Swinging To First-Quarter Profit - And What's Next

Liquidia Corporation recently reported first-quarter 2026 results, with revenue of US$132.87 million and net income of US$52.86 million, compared with US$3.12 million of revenue and a net loss of US$38.37 million a year earlier. This sharp swing to profitability, including basic earnings per share from continuing operations of US$0.60 versus a loss of US$0.45, highlights a major shift in the company’s operating profile. We’ll now examine how this move from loss to profit in the latest...
NYSE:SGHC
NYSE:SGHCHospitality

Reaffirmed 2026 Guidance And New Segments Might Change The Case For Investing In Super Group (SGHC) (SGHC)

Super Group (SGHC) recently reported first-quarter 2026 results, with revenue rising to US$612 million and net income to US$87 million, while reaffirming full-year 2026 guidance targeting at least US$2.55 billion in total revenue. The company also shifted to a new Africa and International segment reporting structure and is stepping up investor outreach through multiple May 2026 conferences and roadshows, giving investors clearer regional transparency and more access to management. We’ll now...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

Should ADMA’s Channel Stuffing Probes and ASCENIV Label Win Require Action From ADMA Biologics (ADMA) Investors?

In early May 2026, ADMA Biologics reported first-quarter 2026 results showing essentially flat sales at US$114.49 million year over year, but net income rose to US$45.33 million and earnings per share increased to US$0.19, alongside updated full-year 2026 revenue guidance of US$530 million to US$560 million. Around the same time, the FDA approved an expanded label for ASCENIV to include pediatric primary humoral immunodeficiency patients as young as two years old, while short seller-driven...